432A — Cliniphar Cashflow Statement
0.000.00%
Last trade - 00:00- ¥1bn
- ¥3bn
- ¥4bn
Annual cashflow statement for Cliniphar, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2024 March 31st | 2025 March 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | JAS | JAS |
| Status: | Final | Final |
| Net Income/Starting Line | -549 | 199 |
| Depreciation | ||
| Non-Cash Items | 720 | -41.3 |
| Unusual Items | ||
| Other Non-Cash Items | ||
| Changes in Working Capital | -121 | -95.2 |
| Change in Accounts Receivable | ||
| Change in Inventories | ||
| Change in Accounts Payable | ||
| Other Operating Cash Flow | ||
| Cash from Operating Activities | 87.6 | 96.5 |
| Capital Expenditures | -40.6 | -43.7 |
| Purchase of Fixed Assets | ||
| Other Investing Cash Flow Items | -348 | -298 |
| Sale/Maturity of Investment | ||
| Purchase of Investments | ||
| Other Investing Cash Flow | ||
| Cash from Investing Activities | -388 | -342 |
| Financing Cash Flow Items | 3.48 | -1.48 |
| Other Financing Cash Flow | ||
| Net Issuance / Retirement of Debt | ||
| Cash from Financing Activities | -2.44 | 193 |
| Foreign Exchange Effects | ||
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | -303 | -51.4 |